Browse studies

Find your next paid study

56 recruiting studies matching your filters

Phase 1 Trial of Nab-Paclitaxel PIPAC (Pressurized Intraperitoneal Aerosolized Chemotherapy) Given in Combination With Second-Line Therapy for Gastric Cancer With Peritoneal Metastases

This phase I trial tests the safety, side effects and best dose of nab-paclitaxel pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in combination w…

Clinical Stage IVB Gastric Cancer AJCC v8Metastatic Gastric AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT06675136

Phase 2

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

This phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroe…

Metastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine TumorStage I Pancreatic Neuroendocrine Tumor AJCC v8+2 more

Estimated

~$10 – $7,500

SWOG Cancer Research NetworkNCT05040360

Phase 1

A Pilot Study of BgRT for Bone Metastases

This clinical trial tests the safety and effectiveness of a single-dose treatment of biology-guided radiation therapy (BgRT) in treating patients with painful …

Metastatic Malignant Neoplasm in the BoneMetastatic Malignant Solid Neoplasm

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT06549478

Phase 3

Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. …

CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more

Estimated

~$10 – $7,500

SWOG Cancer Research NetworkNCT03418961

Phase 1

A Phase 1a/1b Dose Escalation and Dose Expansion Study of NPX887 in Participants With Solid Tumor Malignancies Known to Express B7-H7/HHLA2

NPX887 is a human, antagonistic immunoglobulin G1 (IgG1) monoclonal antibody targeting B7-H7 (HHLA2) that may potentiate an anti-tumor immune response. The goa…

Metastatic Malignant Neoplasm

Estimated

~$10 – $8,750

NextPoint Therapeutics, Inc.NCT06240728

Phase 2

A Phase 2 Randomized Study With a Non-randomized Cohort : Assessing Single-Fraction SBRT Versus Standard Palliative Radiation in Patients With Metastatic Disease (ASTEROID)

This phase II trial studies how well single-fraction stereotactic body radiation therapy (SBRT) works when compared to standard radiation therapy in treating p…

Metastatic Malignant Neoplasm

Estimated

~$10 – $7,500

Roswell Park Cancer InstituteNCT04068649

Observational

Part A: Effect of Prophylactic Vertebroplasty Combined With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)

This clinical trial studies the side effects of stereotactic radiosurgery and how well it works with or without vertebroplasty, separation surgery, or immunoth…

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Spine

Estimated

~$10 – $6,250

Ohio State University Comprehensive Cancer CenterNCT05178472

Phase 1

A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Lung Cancer During Surgical Procedures

This phase I/II trial studies the best dose and timing of panitumumab-IRDye800 in detecting cancer in participants with lung cancer during the surgery. Panitum…

Lung CarcinomaMetastatic Malignant Neoplasm in the LungStage IV Lung Cancer AJCC v8+2 more

Estimated

~$10 – $6,250

Stanford UniversityNCT03582124